Quarterly ResultMay 20, 2026, 04:33 PM
ASP Isotopes Q1 Net Loss $(7.12)M; Revenue $4.18M; Acquired Renergen
AI Summary
ASP Isotopes Inc. reported a net loss attributable to shareholders of $(6.88) million for Q1 2026, an improvement from $(8.45) million in Q1 2025. Total revenue significantly increased by 279% to $4.18 million. The company completed the acquisition of Renergen in January 2026, expanding into liquid helium and LNG production, and deconsolidated its subsidiary Skyline. ASP Isotopes also made progress on its isotope enrichment platforms, targeting initial commercial shipments for C-14, Si-28, and Yb-176 in mid-2026 to Q3 2026.
Key Highlights
- Acquired Renergen in January 2026, expanding into liquid helium and LNG production.
- Deconsolidated Skyline, a Hong Kong construction subsidiary, effective March 29, 2026.
- Net loss attributable to shareholders improved to $(6.88) million from $(8.45) million year-over-year.
- Total revenue surged 279% to $4.18 million for the three months ended March 31, 2026.
- Gross profit increased 410% to $1.67 million from $0.33 million year-over-year.
- Cash and cash equivalents stood at $207.35 million as of March 31, 2026.
- Targeting initial commercial shipments for C-14, Si-28, and Yb-176 in mid-2026 to Q3 2026.
- Net cash used in operating activities increased to $(17.76) million from $(3.17) million year-over-year.
Price Impact
More from ASPI